A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (cyclosporine)/MMF in De Nove Kidney Trans Recip.

Grants and Contracts Details

StatusFinished
Effective start/end date6/18/071/31/10

Funding

  • Astellas Pharma US Inc: $26,501.00